Pharmacokinetics and safety of an engineered anti-feline PD-1 chimeric antibody following repeated intravenous and subcutaneous administration in healthy cats
Pharmacokinetics and safety of an engineered anti-feline PD-1 chimeric antibody following repeated intravenous and subcutaneous administration in healthy cats. // Biological Control. – URL: https://www.sciencedirect.com/science/article/pii/S0165242726001467?dgcid=rss_sd_all
Pharmacokinetics and safety of an engineered anti-feline PD-1 chimeric antibody following repeated intravenous and subcutaneous administration in healthy cats. Biological Control. https://www.sciencedirect.com/science/article/pii/S0165242726001467?dgcid=rss_sd_all
“Pharmacokinetics and safety of an engineered anti-feline PD-1 chimeric antibody following repeated intravenous and subcutaneous administration in healthy cats.” Biological Control.
@article{article7778,
title = {Pharmacokinetics and safety of an engineered anti-feline PD-1 chimeric antibody following repeated intravenous and subcutaneous administration in healthy cats},
journal = {Biological Control},
url = {https://www.sciencedirect.com/science/article/pii/S0165242726001467?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Veterinary Immunology and Immunopathology, Volume 302 Author(s): Emiliano Sosa, Dadín P. Moore, Bibiana Dallard, Lucía M. Campero, M. Andrea Fiorentino, Andrea E. Verna, Juan A. García, Franco...